"Henry Ford Medical Center – New Center One offers a variety of specialty and diagnostic services including allergy, dermatology, endocrinology, pediatrics, rheumatology, sleep disorders and women’s health. There is also on-site laboratory, radiology and pharmacy services. The center is on West Grand Boulevard three blocks east of Henry Ford Hospital."

During the past decade, Henry Ford Medical Center - New Center One conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Medical Center - New Center One" #1 sponsor was "Celgene" with 9 trials, followed by "Henry Ford Health System" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Dermira, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Medical Center - New Center One" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator and "Prosoft Clinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Medical Center - New Center One" are "Crohn Disease" (4 trials), "Acne Vulgaris" (3 trials), "Multiple Myeloma" (3 trials), "Atopic Dermatitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Henry Ford Medical Center - New Center One" in a lesser frequency.

Most popular intervention types in "Henry Ford Medical Center - New Center One" are "Drug" (23 trials), "Other" (6 trials), "Device" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ozanimod" (3 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials), "500 with BP treatment" (1 trials) and "500 without BP treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Medical Center - New Center One" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Henry Ford Medical Center - New Center One". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Henry Ford Medical Center - New Center One, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Medical Center - New Center One, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".